Skip to main content
. 2020 Jul 28;50(10):907–922. doi: 10.4070/kcj.2020.0061

Table 1. Baseline patient demographics.

Overall (n=189) Sapien XT (n=94) Sapien 3 (n=95) p value
Male 93 (49.2) 47 (50.0) 46 (48.4) 0.828
Age (years) 78.1±7.4 77.6±7.4 78.5±7.5 0.380
Follow-up duration (days) 438 444 357 <0.001
BMI (kg/m2) 23.8±3.5 24.0±3.6 23.6±3.5 0.453
Diabetes mellitus 63 (33.3) 35 (37.2) 28 (29.5) 0.258
Hypertension 146 (77.2) 73 (77.7) 73 (76.8) 0.893
Chronic lung disease 44 (23.3) 14 (14.9) 30 (31.6) 0.007
CCr (mL/min) 47.49±21.52 49.26±23.34 45.71±19.47 0.259
CKD>stage 3 38 (20.1) 21 (22.3) 17 (17.9) 0.446
Dialysis 9 (4.8) 5 (5.3) 4 (4.2) 0.747
PAOD 41 (21.7) 19 (20.2) 22 (23.2) 0.623
Extent of CAD* 0.082
Not significant 104 (55.0) 52 (57.1) 52 (55.3)
1 vessel 41 (21.7) 26 (28.6) 15 (16.0)
2 vessels 18 (9.5) 7 (7.7) 11 (11.7)
3 vessels 22 (11.6) 6 (6.6) 16 (17.0)
Atrial fibrillation 26 (13.8) 9 (9.6) 17 (17.9) 0.097
RBBB 15 (7.9) 9 (9.6) 6 (6.3) 0.407
LBBB 3 (1.6) 1 (1.1) 2 (2.1) 1.000
Previous stroke or TIA 20 (10.6) 11 (11.7) 9 (9.5) 0.619
Previous MI 18 (9.5) 9 (9.6) 9 (9.5) 0.981
Previous procedure/surgery
PCI 42 (22.2) 24 (25.5) 18 (18.9) 0.276
CABG 10 (5.3) 6 (6.4) 4 (4.2) 0.536
SAVR 2 (1.1) 1 (1.1) 1 (1.1) 1.000
TAVR 3 (1.6) 3 (3.2) 0 (0.0) 0.121
PPM or ICD 4 (2.1) 3 (3.2) 1 (1.1) 0.368
PPM 3 (1.6) 3 (3.2) -
ICD 1 (0.5) - 1 (1.1)
NYHA 0.067
1 2 (1.1) 2 (2.1) 0 (0.0)
2 45 (23.8) 21 (22.3) 24 (25.3)
3 99 (52.4) 58 (61.7) 41 (43.2)
4 43 (22.8) 13 (13.8) 30 (31.6)
Syncope 10 (5.3) 10 (10.6) 0 (0.0) 0.001
CCS 0.001
None 64 (33.9) 44 (46.8) 20 (21.1)
1 32 (16.9) 10 (10.6) 22 (23.2)
2 45 (23.8) 22 (23.4) 23 (24.2)
3 34 (18.0) 16 (17.0) 18 (18.9)
4 14 (7.4) 2 (2.1) 12 (12.6)
STS-PROM (%) 7.88±6.82 7.25±5.96 8.51±7.55 0.204
Low, STS<4 61 (32.3) 31 (33.0) 30 (31.6)
Intermediate 51 (27.0) 31 (33.0) 20 (21.1)
High, STS≥8 77 (40.7) 32 (34.0) 45 (47.4)
Inoperable conditions 28 (14.8) 20 (21.3) 8 (8.4) 0.013
Severe COPD 17 (9.0) 14 (14.9) 3 (3.2) 0.005
Porcelain aorta 3 (1.6) 3 (3.2) 0 (0.0) 0.121
Previous CABG, LIMA under the sternum 5 (2.6) 2 (2.1) 3 (3.2) 1.000
Severe frailty 4 (2.1) 2 (2.1) 2 (2.1) 1.000
Bicuspid 10 (5.3) 6 (6.4) 4 (4.2) 0.536
Mean pressure gradient (mmHg) 50.0±18.6 51.4±19.5 48.7±17.6 0.321
Peak velocity (m/s) 4.45±0.75 4.49±0.74 4.41±0.75 0.472
EOA (cm2) 0.74±0.20 0.74±0.18 0.73±0.21 0.758
EOAI (cm2/m2) 0.47±0.12 0.46±0.11 0.47±0.13 0.816
Ejection fraction (%) 55.8±11.7 56.8±11.9 54.8±11.5 0.237
Annular diameter (mm) 22.1±2.9 22.0±3.4 22.3±2.3 0.594
Aortic regurgitation>mild 49 (25.9) 21 (22.3) 28 (29.5) 0.263
Mitral regurgitation>mild 34 (18.0) 11 (11.7) 23 (24.2) 0.025

Follow-up duration is presented as median value. Other values are presented as number of patients (%) or mean±standard deviation.

BMI = body mass index; CABG = coronary artery bypass grafting; CAD = coronary artery disease; CCr = creatinine clearance; CCS = Canadian Cardiovascular Society grading of angina pectoris; CKD = chronic kidney disease; COPD = chronic obstructive pulmonary disease; EOA = effective orifice area; EOAI = effective orifice area index; ICD = implantable cardioverter defibrillator; LBBB = left bundle branch block; LIMA = left internal mammary artery; MI = myocardial infarction; NYHA = New York Heart Association; PAOD = peripheral arterial occlusive disease; PCI = percutaneous coronary intervention; PPM = permanent pacemaker; RBBB = right bundle branch block; SAVR = surgical aortic valve replacement; STS = Society of Thoracic Surgeons; STS-PROM = Society of Thoracic Surgeons-Predicted Risk Of Mortality; TAVR = transcatheter aortic valve replacement; TIA = transient ischemic attack.

*Left main coronary artery disease was considered 2-vessel disease.